Primary HIV infection: Molecular approaches in diagnosis and monitoring

D. Ciuffreda, B. Capiluppi, E. Mastrorilli, G. Balconi, G. Tambussi, A. Lazzarin, F. Lillo

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: The aim of this study was to evaluate, in patients with primary HIV infection (PHI), the modification of HIV molecular parameters (HIV, RNA, and DNA) induced by highly active antiretroviral therapy (HAART) in peripheral blood mononuclear cells (PBMC) and in lymphoid tissue (LNMC). Methods: Nineteen patients with primary HIV infection, 4 women and 15 men with an average age of 35 years (range 27-62), were included in this study. Ten patients received 4 drugs: zidovudine plus lamivudine plus saquinavir plus ritonavir, 7 patients received 3 drugs: zidovudine plus lamivudine plus saquinavir and 2 patients received a different combination of 3 drugs: zidovudine plus lamivudine plus indinavir. As control group we included 8 patients who had been enrolled in a placebo-controlled trial of zidovudine between 1991 and 1995: four received placebo and 4 were treated with zidovudine alone. Peripheral blood samples and lymphoid tissue obtained by echo-driven fine needle biopsies were drawn to monitor molecular HIV parameters. A quantitative in house PCR method in the HIV gag region was used to monitor viral DNA burden and the NASBA system for viremia. Results: A certain heterogeneity in the baseline values of HIV, DNA, and RNA was observed. Early HAART determined a rapid recovery of the CD4 cell number with normalisation of the CD4/CD8 ratio in most patients. HIV-RNA levels dropped to undetectable levels after a few months of therapy and HIV-DNA was consistently reduced although it never reached undetectable levels. Lymph-node biopsies were well tolerated due to the non-invasive sampling, however an optimisation of the method is needed to improve cell recovery. In the valuable samples the amount of HIV DNA recovered is comparable to that from peripheral blood samples, both at baseline and at follow-up.

Original languageEnglish
Pages (from-to)63-67
Number of pages5
JournalJournal of Biological Regulators and Homeostatic Agents
Volume14
Issue number1
Publication statusPublished - 2000

Fingerprint

HIV infections
HIV Infections
Zidovudine
HIV
monitoring
Lamivudine
DNA
Saquinavir
RNA
Highly Active Antiretroviral Therapy
drugs
Lymphoid Tissue
therapeutics
placebos
biopsy
Self-Sustained Sequence Replication
Placebos
sampling
Indinavir
viremia

Keywords

  • Fine needle biopsy
  • HAART
  • Lymph-node
  • PBMC/LNMC
  • Proviral DNA

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Endocrinology
  • Physiology
  • Immunology
  • Medicine (miscellaneous)
  • Endocrinology, Diabetes and Metabolism
  • Physiology (medical)

Cite this

Ciuffreda, D., Capiluppi, B., Mastrorilli, E., Balconi, G., Tambussi, G., Lazzarin, A., & Lillo, F. (2000). Primary HIV infection: Molecular approaches in diagnosis and monitoring. Journal of Biological Regulators and Homeostatic Agents, 14(1), 63-67.

Primary HIV infection : Molecular approaches in diagnosis and monitoring. / Ciuffreda, D.; Capiluppi, B.; Mastrorilli, E.; Balconi, G.; Tambussi, G.; Lazzarin, A.; Lillo, F.

In: Journal of Biological Regulators and Homeostatic Agents, Vol. 14, No. 1, 2000, p. 63-67.

Research output: Contribution to journalArticle

Ciuffreda, D, Capiluppi, B, Mastrorilli, E, Balconi, G, Tambussi, G, Lazzarin, A & Lillo, F 2000, 'Primary HIV infection: Molecular approaches in diagnosis and monitoring', Journal of Biological Regulators and Homeostatic Agents, vol. 14, no. 1, pp. 63-67.
Ciuffreda, D. ; Capiluppi, B. ; Mastrorilli, E. ; Balconi, G. ; Tambussi, G. ; Lazzarin, A. ; Lillo, F. / Primary HIV infection : Molecular approaches in diagnosis and monitoring. In: Journal of Biological Regulators and Homeostatic Agents. 2000 ; Vol. 14, No. 1. pp. 63-67.
@article{f3f5fc2024bb41ae99bea442fd1ea543,
title = "Primary HIV infection: Molecular approaches in diagnosis and monitoring",
abstract = "Objective: The aim of this study was to evaluate, in patients with primary HIV infection (PHI), the modification of HIV molecular parameters (HIV, RNA, and DNA) induced by highly active antiretroviral therapy (HAART) in peripheral blood mononuclear cells (PBMC) and in lymphoid tissue (LNMC). Methods: Nineteen patients with primary HIV infection, 4 women and 15 men with an average age of 35 years (range 27-62), were included in this study. Ten patients received 4 drugs: zidovudine plus lamivudine plus saquinavir plus ritonavir, 7 patients received 3 drugs: zidovudine plus lamivudine plus saquinavir and 2 patients received a different combination of 3 drugs: zidovudine plus lamivudine plus indinavir. As control group we included 8 patients who had been enrolled in a placebo-controlled trial of zidovudine between 1991 and 1995: four received placebo and 4 were treated with zidovudine alone. Peripheral blood samples and lymphoid tissue obtained by echo-driven fine needle biopsies were drawn to monitor molecular HIV parameters. A quantitative in house PCR method in the HIV gag region was used to monitor viral DNA burden and the NASBA system for viremia. Results: A certain heterogeneity in the baseline values of HIV, DNA, and RNA was observed. Early HAART determined a rapid recovery of the CD4 cell number with normalisation of the CD4/CD8 ratio in most patients. HIV-RNA levels dropped to undetectable levels after a few months of therapy and HIV-DNA was consistently reduced although it never reached undetectable levels. Lymph-node biopsies were well tolerated due to the non-invasive sampling, however an optimisation of the method is needed to improve cell recovery. In the valuable samples the amount of HIV DNA recovered is comparable to that from peripheral blood samples, both at baseline and at follow-up.",
keywords = "Fine needle biopsy, HAART, Lymph-node, PBMC/LNMC, Proviral DNA",
author = "D. Ciuffreda and B. Capiluppi and E. Mastrorilli and G. Balconi and G. Tambussi and A. Lazzarin and F. Lillo",
year = "2000",
language = "English",
volume = "14",
pages = "63--67",
journal = "Journal of Biological Regulators and Homeostatic Agents",
issn = "0393-974X",
publisher = "Biolife s.a.s.",
number = "1",

}

TY - JOUR

T1 - Primary HIV infection

T2 - Molecular approaches in diagnosis and monitoring

AU - Ciuffreda, D.

AU - Capiluppi, B.

AU - Mastrorilli, E.

AU - Balconi, G.

AU - Tambussi, G.

AU - Lazzarin, A.

AU - Lillo, F.

PY - 2000

Y1 - 2000

N2 - Objective: The aim of this study was to evaluate, in patients with primary HIV infection (PHI), the modification of HIV molecular parameters (HIV, RNA, and DNA) induced by highly active antiretroviral therapy (HAART) in peripheral blood mononuclear cells (PBMC) and in lymphoid tissue (LNMC). Methods: Nineteen patients with primary HIV infection, 4 women and 15 men with an average age of 35 years (range 27-62), were included in this study. Ten patients received 4 drugs: zidovudine plus lamivudine plus saquinavir plus ritonavir, 7 patients received 3 drugs: zidovudine plus lamivudine plus saquinavir and 2 patients received a different combination of 3 drugs: zidovudine plus lamivudine plus indinavir. As control group we included 8 patients who had been enrolled in a placebo-controlled trial of zidovudine between 1991 and 1995: four received placebo and 4 were treated with zidovudine alone. Peripheral blood samples and lymphoid tissue obtained by echo-driven fine needle biopsies were drawn to monitor molecular HIV parameters. A quantitative in house PCR method in the HIV gag region was used to monitor viral DNA burden and the NASBA system for viremia. Results: A certain heterogeneity in the baseline values of HIV, DNA, and RNA was observed. Early HAART determined a rapid recovery of the CD4 cell number with normalisation of the CD4/CD8 ratio in most patients. HIV-RNA levels dropped to undetectable levels after a few months of therapy and HIV-DNA was consistently reduced although it never reached undetectable levels. Lymph-node biopsies were well tolerated due to the non-invasive sampling, however an optimisation of the method is needed to improve cell recovery. In the valuable samples the amount of HIV DNA recovered is comparable to that from peripheral blood samples, both at baseline and at follow-up.

AB - Objective: The aim of this study was to evaluate, in patients with primary HIV infection (PHI), the modification of HIV molecular parameters (HIV, RNA, and DNA) induced by highly active antiretroviral therapy (HAART) in peripheral blood mononuclear cells (PBMC) and in lymphoid tissue (LNMC). Methods: Nineteen patients with primary HIV infection, 4 women and 15 men with an average age of 35 years (range 27-62), were included in this study. Ten patients received 4 drugs: zidovudine plus lamivudine plus saquinavir plus ritonavir, 7 patients received 3 drugs: zidovudine plus lamivudine plus saquinavir and 2 patients received a different combination of 3 drugs: zidovudine plus lamivudine plus indinavir. As control group we included 8 patients who had been enrolled in a placebo-controlled trial of zidovudine between 1991 and 1995: four received placebo and 4 were treated with zidovudine alone. Peripheral blood samples and lymphoid tissue obtained by echo-driven fine needle biopsies were drawn to monitor molecular HIV parameters. A quantitative in house PCR method in the HIV gag region was used to monitor viral DNA burden and the NASBA system for viremia. Results: A certain heterogeneity in the baseline values of HIV, DNA, and RNA was observed. Early HAART determined a rapid recovery of the CD4 cell number with normalisation of the CD4/CD8 ratio in most patients. HIV-RNA levels dropped to undetectable levels after a few months of therapy and HIV-DNA was consistently reduced although it never reached undetectable levels. Lymph-node biopsies were well tolerated due to the non-invasive sampling, however an optimisation of the method is needed to improve cell recovery. In the valuable samples the amount of HIV DNA recovered is comparable to that from peripheral blood samples, both at baseline and at follow-up.

KW - Fine needle biopsy

KW - HAART

KW - Lymph-node

KW - PBMC/LNMC

KW - Proviral DNA

UR - http://www.scopus.com/inward/record.url?scp=0034456715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034456715&partnerID=8YFLogxK

M3 - Article

C2 - 10763897

AN - SCOPUS:0034456715

VL - 14

SP - 63

EP - 67

JO - Journal of Biological Regulators and Homeostatic Agents

JF - Journal of Biological Regulators and Homeostatic Agents

SN - 0393-974X

IS - 1

ER -